Assure (NASDAQ:IONM) versus Daxor (NASDAQ:DXR) Financial Analysis

Daxor (NASDAQ:DXR) and Assure (NASDAQ:IONM) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.

Profitability

This table compares Daxor and Assure’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Daxor	N/A	N/A	N/A
Assure	-25,178.32%	N/A	-249.78%

Earnings & Valuation

This table compares Daxor and Assure”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Daxor	N/A	N/A	N/A	N/A	N/A
Assure	$149,000.00	0.51	-$26.08 million	N/A	N/A

Daxor has higher earnings, but lower revenue than Assure.

Risk and Volatility

Daxor has a beta of -0.55, suggesting that its share price is 155% less volatile than the S&P 500. Comparatively, Assure has a beta of 1.76, suggesting that its share price is 76% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Daxor and Assure, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Daxor	0	0	1	0	3.00
Assure	0	0	0	0	N/A

Daxor currently has a consensus price target of $24.75, indicating a potential upside of 185.47%. Given Daxor’s higher probable upside, analysts clearly believe Daxor is more favorable than Assure.

Insider and Institutional Ownership

1.3% of Daxor shares are held by institutional investors. Comparatively, 3.3% of Assure shares are held by institutional investors. 59.0% of Daxor shares are held by company insiders. Comparatively, 3.8% of Assure shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Daxor beats Assure on 5 of the 8 factors compared between the two stocks.

About Daxor

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

About Assure

Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. It offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures. The company delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures. Assure Holdings Corp. is based in Englewood, Colorado.